KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Non-cash Items (2016 - 2022)

Historic Non-cash Items for Abbott Laboratories (ABT) over the last 14 years, with Q1 2022 value amounting to $1.4 billion.

  • Abbott Laboratories' Non-cash Items rose 604394.68% to $1.4 billion in Q1 2022 from the same period last year, while for Mar 2022 it was $1.4 billion, marking a year-over-year increase of 604394.68%. This contributed to the annual value of $2.1 billion for FY2021, which is 3204.88% up from last year.
  • According to the latest figures from Q1 2022, Abbott Laboratories' Non-cash Items is $1.4 billion, which was up 604394.68% from $2.1 billion recorded in Q4 2021.
  • Over the past 5 years, Abbott Laboratories' Non-cash Items peaked at $2.1 billion during Q4 2021, and registered a low of $996.0 during Q4 2018.
  • For the 5-year period, Abbott Laboratories' Non-cash Items averaged around $895.2 million, with its median value being $1.1 billion (2018).
  • As far as peak fluctuations go, Abbott Laboratories' Non-cash Items tumbled by 9999.55% in 2018, and later skyrocketed by 11425692811.24% in 2019.
  • Abbott Laboratories' Non-cash Items (Quarter) stood at $996.0 in 2018, then skyrocketed by 114256928.11% to $1.1 billion in 2019, then skyrocketed by 36.82% to $1.6 billion in 2020, then soared by 32.05% to $2.1 billion in 2021, then fell by 29.72% to $1.4 billion in 2022.
  • Its Non-cash Items stands at $1.4 billion for Q1 2022, versus $2.1 billion for Q4 2021 and $1.6 billion for Q3 2021.